SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Intercare Insurance Solutions, a HUB International Co., is holding a Corporate Wellness Symposium June 19.
(Editor’s note: This is the final column on biotechnology and health care from Meghana Keshavan, who leaves the San Diego Business Journal as of this issue to join a national online publication focused on innovation in the health care industry.)
Biotech: Company Sees Huge Market for Biosimilars As Patents on Biologics End
Pfenex Inc., a spinoff of Dow Chemical Co., is the latest San Diego biotech to file for an initial public offering. The company is looking to raise $74.8 million as it focuses development on a growing class of drugs called biosimilars, which are projected to make a large dent in big pharma sales as patents for biologic drugs expire.
Possible approval of weight-loss drug pushed back to September.
The property was fully leased.
The San Diego Business Journal is now accepting nominations for 2014 Healthcare Champions awards, which honors individuals within the San Diego community who have demonstrated exceptional leadership and innovation in the health care industry.
Former home of La Jolla drug store was bought.
Isis Pharmaceuticals Inc. has received a large milestone payment from AstraZeneca PLC.
Venture capital veteran from Boston joining San Diego biotech as CEO.
Pfenex Inc., a spinoff of Dow Chemical Co., is the latest San Diego biotech to file for an initial public offering, looking to raise $74.8 million to fund its development of biosimilars.
I chatted recently with Paul Cleveland, a veteran biotech finance guy who has recently been brought on as president and chief financial officer for the newly public gene therapy company Celladon Corp. Cleveland most recently was CFO of Aragon Pharmaceuticals Inc., a San Diego drugmaker sold to Johnson & Johnson last August for $1 billion.
biotech: Supreme Court Ruling on Gene Patent Case Clears Path to Competition
San Diego’s Pathway Genomics Corp. is employing a social entrepreneurship model as it launches its new genetic test for breast cancer — entering a market made more high profile and competitive after a U.S. Supreme Court ruling last year that invalidated patents on genes.
Michael Covert is stepping down after more than a decade as CEO of Palomar Health, heading to Texas in August to run six Houston-area hospitals.
HEALTH: Cos. Seek to Tap Into Consumers’ Desire to Take Control of Their Health
Ayub Khattak’s big idea started with the swine flu.
The National Institutes of Health has awarded up to $25 million to the La Jolla-based J. Craig Venter Institute to study the genetics of infectious diseases like malaria and influenza.